Goldman Sachs’s Milestone Pharmaceuticals MIST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $232K | Buy |
+119,449
| New | +$232K | ﹤0.01% | 4655 |
|
|
2025
Q1 | – | Sell |
-942,407
| Closed | -$2.22M | – | 5195 |
|
|
2024
Q4 | $2.22M | Sell |
942,407
-410,660
| -30% | -$969K | ﹤0.01% | 3402 |
|
|
2024
Q3 | $2.06M | Hold |
1,353,067
| – | – | ﹤0.01% | 3352 |
|
|
2024
Q2 | $1.79M | Hold |
1,353,067
| – | – | ﹤0.01% | 3260 |
|
|
2024
Q1 | $2.42M | Hold |
1,353,067
| – | – | ﹤0.01% | 3088 |
|
|
2023
Q4 | $2.26M | Sell |
1,353,067
-1,205,657
| -47% | -$2.01M | ﹤0.01% | 3125 |
|
|
2023
Q3 | $7.93M | Buy |
2,558,724
+3,437
| +0.1% | +$10.7K | ﹤0.01% | 2147 |
|
|
2023
Q2 | $7.28M | Buy |
2,555,287
+2,822
| +0.1% | +$8.04K | ﹤0.01% | 2296 |
|
|
2023
Q1 | $10.1M | Sell |
2,552,465
-94,651
| -4% | -$373K | ﹤0.01% | 2008 |
|
|
2022
Q4 | $10.5M | Buy |
2,647,116
+2,542,619
| +2,433% | +$10.1M | ﹤0.01% | 2091 |
|
|
2022
Q3 | $960K | Buy |
104,497
+92,493
| +771% | +$850K | ﹤0.01% | 3853 |
|
|
2022
Q2 | $74K | Hold |
12,004
| – | – | ﹤0.01% | 5195 |
|
|
2022
Q1 | $77K | Hold |
12,004
| – | – | ﹤0.01% | 5380 |
|
|
2021
Q4 | $79K | Hold |
12,004
| – | – | ﹤0.01% | 5273 |
|
|
2021
Q3 | $69K | Hold |
12,004
| – | – | ﹤0.01% | 5128 |
|
|
2021
Q2 | $66K | Hold |
12,004
| – | – | ﹤0.01% | 5209 |
|
|
2021
Q1 | $70K | Sell |
12,004
-10,246
| -46% | -$59.7K | ﹤0.01% | 5092 |
|
|
2020
Q4 | $149K | Buy |
22,250
+10,246
| +85% | +$68.6K | ﹤0.01% | 4366 |
|
|
2020
Q3 | $88K | Buy |
+12,004
| New | +$88K | ﹤0.01% | 4250 |
|